Jelena Lujic, PhD,
Research Associate $200,000 / 2 years Awarded 2024 |
Jelena LujicCornell University
Ithaca, NY About
Dr. Lujic is a dedicated researcher with extensive experience in reproductive biology and antibody characterization. Dr. Lujic's collaborative approach and focus on open science will ensure that the platform benefits the entire male contraceptive research community. Our Grant
MCI is proud to support this innovative project. This platform aligns with our mission to provide researchers with the tools they need to advance the development of safe, effective, and reversible male contraceptives. |
Building Better Tools: Dr. Lujic's Open Science Platform
Publications
Monteiro FL, Voskuil JLA, Williams C. YCharOS protocol for antibody validation. Nat Protoc. Published online December 17, 2024. doi:10.1038/s41596-024-01108-6
Biddle MS, Virk HS. YCharOS open antibody characterisation data: Lessons learned and progress made. F1000Res. 2023;12:1344. Published 2023 Oct 16. doi:10.12688/f1000research.141719.1
Kahn RA, Virk H, Laflamme C, et al. Antibody characterization is critical to enhance reproducibility in biomedical research. Elife. 2024;13:e100211. Published 2024 Aug 14. doi:10.7554/eLife.100211
Ayoubi R, et al. A consensus platform for antibody characterization. Nat Protoc. Published online December 17, 2024. doi.10.1038/s41596-024-01095-8
Monteiro FL, Voskuil JLA, Williams C. YCharOS protocol for antibody validation. Nat Protoc. Published online December 17, 2024. doi:10.1038/s41596-024-01108-6
Biddle MS, Virk HS. YCharOS open antibody characterisation data: Lessons learned and progress made. F1000Res. 2023;12:1344. Published 2023 Oct 16. doi:10.12688/f1000research.141719.1
Kahn RA, Virk H, Laflamme C, et al. Antibody characterization is critical to enhance reproducibility in biomedical research. Elife. 2024;13:e100211. Published 2024 Aug 14. doi:10.7554/eLife.100211
Ayoubi R, et al. A consensus platform for antibody characterization. Nat Protoc. Published online December 17, 2024. doi.10.1038/s41596-024-01095-8
Meet MCI's Grantees & Fellows!
Our grantees and fellows represent some of the finest minds in the male contraception research community from around the world.
At Male Contraceptive Initiative, we prioritize funding research that aligns with our mission of driving male contraception closer to clinical trials. We strategically allocate our resources to support a diverse range of projects, focusing on non-hormonal and reversible methods that have the potential to meet the needs of a broader population. Our goal is to catalyze progress in this field and bring innovative male birth control options to market.
Discover the innovative research being conducted by our grantees and fellows by clicking on the buttons below:
At Male Contraceptive Initiative, we prioritize funding research that aligns with our mission of driving male contraception closer to clinical trials. We strategically allocate our resources to support a diverse range of projects, focusing on non-hormonal and reversible methods that have the potential to meet the needs of a broader population. Our goal is to catalyze progress in this field and bring innovative male birth control options to market.
Discover the innovative research being conducted by our grantees and fellows by clicking on the buttons below:
Looking for Something?
Welcome to your comprehensive resource on the future of male contraception! We have packed this site with vital information, and to help you find exactly what you need, we've created a detailed guide. Please use the Table of Contents on our homepage to easily navigate to the research, news, or resources that interest you most. This will ensure you can explore all of our important content with ease. You can access the Table of Contents by clicking on the button below: